Biotech and Pharma

The growth for Vertex’s Journavax painkiller is just beginning to ramp up, given the potential size of the nonaddictive drug market.

Alphabet stock rises but Microsoft and Meta fall after the tech giants report quarterly earnings.

Gilead said its new, closely watched HIV drug is now available to 75% of U.S. patients.

Denmark’s Novo offers $56.50 a share in cash for Metsera, plus potentially a further $21.25 a share based on clinical and regulatory milestones.

Merck boosts its full-year outlook as third-quarter earnings top estimates following strong demand for its blockbuster cancer drug.

Eli Lilly’s third-quarter earnings top analysts’ estimates. Revenue rises 54% from a year earlier.

While total revenue grew in the quarter, competition weighed on the drugmaker’s legacy portfolio.

Nvidia rises after President Donald Trump says he may discuss the company’s advanced Blackwell chips with Chinese President Xi Jinping when they meet Thursday. Earnings are expected Wednesday from Microsoft, Alphabet, and Meta Platforms.

Technical indicators flash bullish for UnitedHealth Group and Agilent Technologies.

UPS rises after the shipping and logistics giant posts better-than-expected third-quarter earnings, and Microsoft’s market cap crosses $4 trillion for the first time.

Qualcomm soars after introducing new artificial-intelligence servers meant to compete with Nvidia and AMD, while MP Materials falls as Treasury Secretary Scott Bessent says he expects China to defer its tightened export controls on rare-earth materials.

Organon CEO Kevin Ali resigns after an internal board investigation.

Stifel analyst Paul Matteis called the $12 billion deal “highly validating for the space.”

Mag 7 earnings and Fed decision headline busy week, officials talk of progress ahead of Trump-Xi meeting, Novartis agrees to buy Avidity, and more news to start your day.

The FDA approved the treatment in 2020 but withdrew the go-ahead in 2022.

Tesla rises and IBM falls after reporting quarterly earnings, while quantum-computing stocks soar on a report the Trump administration is considering taking equity stakes in several companies in exchange for federal funding. The Commerce Department denied the report.

The company’s new orders soared 49% in the third quarter from a year ago.

The stock of the cancer test company shot up before settling back down.

Netflix revenue is rising, hiring trends are emerging, Novo Nordisk’s boardroom drama escalates, and more news to start your day.

The board turmoil represents a breakdown in relations between the company and its controlling shareholder.

Apple stock rises after analysts at Loop Capital boost their rating on the iPhone maker to Buy from Hold, while Nvidia unveils the first Blackwell wafer made in the U.S. with a chip produced by Taiwan Semiconductor Manufacturing.

Jana Partners plans to push for strategic alternatives at Cooper, The Wall Street Journal reports.

Grail shared the results of it Pathfinder 2 study during a meeting of the European Society for Medical Oncology in Berlin on Saturday.

Barron’s called Holz to ask about what’s happened to the biotech sector since our healthcare roundtable.